MedTrace Logo

Observational Study of Males With Creatine Transporter Deficiency

NCT02931682 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2022-11-14

No results posted yet for this study

Summary

The objectives of this study are to illustrate the clinical, neuro/electrophysiologic, biochemical, and developmental status and progression of patients with Creatine Transporter Deficiency (CTD) and to evaluate the utility of performance-based and other measures in the CTD population.

Conditions

  • Creatine Deficiency, X-linked

Sponsors & Collaborators

Principal Investigators

  • Medical Director · Ultragenyx Pharmaceutical Inc

Eligibility

Min Age
6 Months
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2022-10-24
Completion
2022-10-24

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02931682 on ClinicalTrials.gov